Continuous glucose monitoring: A transformative tool for health, prevention and longevity

Continuous glucose monitors (CGMs) have revolutionized diabetes management, but their use is gaining popularity beyond clinical boundaries. Increasingly, CGMs are being embraced by health-conscious individuals, wellness advocates, and longevity enthusiasts as a tool for optimizing lifestyle, preventing chronic disease, and enhancing lifespan. This article explores the medical science behind CGMs and their potential to improve health outcomes for both diabetic and non-diabetic populations.

Understanding continuous glucose monitors (CGMs) is essential for the general public, both in terms of how they work and the technology behind them. CGMs are wearable biosensors that measure glucose levels in the interstitial fluid beneath the skin. They use enzymatic electrochemical detection to convert glucose levels into electrical signals, which are transmitted to a receiver or smartphone app. These devices offer real-time glucose tracking, trend analysis and alerts and integrate data with health apps. With recent approvals, common devices such as Dexcom, Stelo and Abbot Lingo are now available over the counter for nondiabetic users. This shift has been accelerated by marketing firms, advertisers, and influencers who increasingly promote CGMs as tools for prevention, optimization and longevity, rather than strictly for diabetes management. 

CGMs are clinically proven to help people with Type 1 or insulin-treated or Type 2 diabetes. Studies show that they help lower HbA1c levels by 0.4% or more, ^{footnote 11} increase time-in-range (TIR), helping users maintain glucose between 70-180 mg/dL and reducing complications. They further reduce hypoglycemic risk through real-time alerts to prevent dangerous lows. Ultimately, CGMs improve quality of life by reducing the need for finger pricks and supporting better glycemic control.

More recently, CGMs are increasingly used by nondiabetic individuals to support lifestyle and nutrition goals. The CGM apps show how specific foods affect glucose levels, highlighting spikes and crashes that may be especially relevant for those at risk of prediabetes. This insight helps users tailor their diet to reduce post‑meal hyperglycemia, improve energy by stabilizing glucose fluctuations and better understand their body’s response. Even healthy individuals can experience glucose spikes into prediabetic ranges after carbohydrate‑rich meals.

Metabolic health and insulin sensitivity

CGMs can detect early signs of insulin resistance, which is often missed by fasting glucose or A1c tests. Research from the University of Tokyo [BB1] found that CGM-derived metrics like glucose autocorrection variability outperform traditional markers in predicting insulin sensitivity. ^{footnote 22} This early detection allows for: 

• Timely lifestyle interventions
• Prevention of Type 2 diabetes
• Reduction in cardiometabolic risk

Exercise optimization and recovery

Athletes use CGMs to:

• Monitor glucose during training
• Time carbohydrate intake for peak performance
• Avoid post-exercise hypoglycemia

CGMs also help assess metabolic flexibility, the body’s ability to switch between fuel sources, which is a marker of longevity.

Sleep and stress monitoring

Poor sleep and chronic stress can elevate cortisol, impair insulin sensitivity and increase glucose variability. CGMs provide feedback on:

• Nocturnal glucose trends
• Stress-induced spikes
• Impact of relaxation techniques

Glucose variability: A silent driver of aging and disease

The fluctuation in glucose levels is recognized as a risk factor for aging and chronic disease.

• Oxidative stress: Increases reactive oxygen species, damaging cells.
• Inflammation: Spikes trigger inflammatory cytokines.
• Endothelial dysfunction: Impairs vascular health, promoting atherosclerosis

Despite their promise, CGMs have important limitations. Monthly costs typically range from $135 to $400 and are often not covered for people without diabetes. Effective use also requires education or professional guidance to interpret the large volume of data appropriately. Technically, interstitial glucose measurements can lag behind blood glucose by 5-15 minutes, and behaviourally, continuous tracking may contribute to anxiety or obsessive monitoring in some individuals.

Even with these challenges, CGMs offer a powerful look into metabolic health. While they remain indispensable for people managing diabetes, they are increasingly being adopted by nondiabetic individuals seeking deeper insight into nutrition, exercise, stress and sleep, which are core drivers of long-term health. As interest in prevention and longevity grows, marketing firms, targeted ads and wellness influencers have accelerated this trend by positioning CGMs as everyday optimization tools rather than strictly medical devices. Looking ahead, continued research may solidify their place in preventive medicine, helping individuals detect metabolic dysfunction early, personalize their lifestyle and extend their healthspan.

^{1Footnote 1 details}​ https://pmc.ncbi.nlm.nih.gov/articles/PMC7547935/

²Footnote 2 details​ https://www.u-tokyo.ac.jp/focus/en/press/z0508_00403.html

Disclaimer:

This article is for information purposes only and is not intended to provide insurance, financial, legal or health advice, and should not be relied upon in that regard. BMO Life Assurance Company does not provide any such advice to the policyholder or to the insurance advisor. Facts or information provided in this article are believed to be reliable and accurate, but we cannot guarantee that it is reliable and accurate at all times.

Insurer: BMO Life Assurance Company

1104E